- Equity Espresso
- Posts
- Resources Rally, While City Chic Gets Its Groove Back
Resources Rally, While City Chic Gets Its Groove Back


Good Evening,
Welcome to Equity Espresso’s Market Recap.
The Australian stock market rebounded on Tuesday, with the S&P/ASX 200 index gaining 0.48% to close at 8,231.0 points, gaining back some of yesterday’s 1.2% decline. Eight out of eleven sectors finished positive, with Materials (+1.51%) and Real Estate (+1.18%) stocks leading the advance.
Mining giants benefited from iron ore prices climbing above US$100/t for the first time in two weeks, with Fortescue (+2.89%) and BHP Group (+1.44%) rising. Energy (+1.17%) was another top performer, boosted by Coal stocks, which saw significant gains despite recent price weakness. Whitehaven Coal (+6.61%) surged while Yancoal (+2.76%) posted solid gains.
Company News
City Chic (+14.58%) shares surged on the back of a trading update. Despite reporting a 3.6% drop in global sales revenue to $69.5m, a strong holiday trading period, particularly in ANZ (+9.0%), drove the share price higher. The company achieved significant margin improvements across all regions, with an 8.5% gross margin growth. EBITDA is provided to be $3-4m, marking a substantial recovery from the previous $4.4m loss.
Energy Transition Minerals (+16.28%) says it plans to visit Greenland in February to improve government relations amid ongoing legal disputes over its proposed rare earths mine in the Danish territory. The announcement comes after former foreign minister Julie Bishop was hired to advise the company.
Ingenia Communities Group (+15.04%) has raised its FY25 guidance, now targeting EBIT of $162-165 million (20-23% growth) versus previous guidance of $148-155 million. The company also increased underlying EPS targets to 29.0-30.0 cents from 24.4-25.6 cents, citing strong execution and first-half performance.
Mesoblast (-9.25%) shares fell after finalising a capital raise totalling $260 million at $2.50 per share. The proceeds will be used to fund the US commercial launch of its proprietary cell therapy Ryoncil.
PWR Holdings' (+2.15%) secured an $8.9 million U.S. government contract for advanced cooling solutions, marking its largest aerospace and defence order since entering the sector in 2020.
ASX Indices![]() | ASX Sector Performance![]() |
Wall Street
It was a tale of two stories on the U.S. market Monday, with the Dow Jones (+0.86%) leading the way of the major indices, with the S&P 500 (+0.16%) managing to claw back from early losses to finish marginally higher. In contrast, the tech-heavy Nasdaq (-0.38%) declined, reflecting the ongoing pressure from elevated Treasury yields, which saw the 10-year note touching a 14-month high of 4.805%.
There was a clear rotation into cyclical and commodity-linked areas, as Energy (+2.25%) and Materials (+2.21%) sectors gained over 2%, while traditionally defensive sectors like Utilities (-1.19%) struggled alongside Technology (-0.87%).
Moderna (-16.80%) shares tanked after it reduced its 2025 sales forecast by $1 billion to $1.5-2.5 billion, down from the previous $2.5-3.5 billion guidance. Revenue will primarily come from Covid and RSV vaccines, with most sales expected in the second half of 2025.
U.S. Indices![]() | Fear & Greed Index![]() |
S&P500 Sector Performance

Economic Data
Australian Building Permits fell by 3.6% month-on-month to 14,998 units in November 2024, reversing sharply from a 5.2% gain in the previous month and matching preliminary estimates.
Australian Consumer Sentiment decreased by 0.7% to 92.1 points in January 2025, marking its second consecutive monthly decline.
Sponsor
Learn Value Investing from Wharton Online and Wall Street Prep
Learn from the top Value Investors on Wall Street
Strengthen your network through invitation-only LinkedIn groups
Earn a certificate from Wharton Online and Wall Street Prep
Quick Singles
🌎️ Around The Globe
Amazon is scaling back its diversity and inclusion programs, citing a focus on "proven outcomes." VP Candi Castleberry announced in an internal memo that the company will phase out "outdated programs" as part of a broader initiative review.
Apple faces a £1.5 billion U.K. antitrust trial starting Monday, challenging its App Store's 30% commission fees. This marks the first major Big Tech class action lawsuit to reach British courts over alleged market dominance abuse.
Chick-fil-A is automating its drink-making process, eliminating approximately 10,000 labour hours daily across its restaurant network by replacing manual lemon squeezing with machines.
JPMorgan Chase is facing employee pushback on its return-to-office mandate, leading the bank to disable comments on an internal announcement after staff expressed opposition to ending remote work options.
A U.S. appeals court reinstated a lawsuit against Pfizer's diversity fellowship program by conservative group Do No Harm. The court reversed its previous ruling requiring plaintiffs to identify affected members by name in discrimination cases.
Robinhood's two broker-dealer units will pay $45 million to settle SEC charges over multiple securities law violations, including delayed suspicious activity reporting, inadequate identity theft protection, and insufficient cybersecurity measures.
Markets
ASX Company Movers

Commodity Prices

Bonds

Forex

Global Health Check

ETF Prices
🔍️ ETF Watch
Want to see how one of your ETFs compares to the rest?
Please reply to this e-mail and tell us an ETF or two you want to be included in the tables below.
Australian Index

Australian Sectors

Global Indices & Sectors

Global Strategy

Property & Infrastructure

Fixed Income

Mixed Assets

Geared

*1-year, 3-year and 5-year returns are calculated as of November 30 2024.
The Last Word
How are we doing?
We always love hearing from our readers and are constantly seeking feedback.
How are we doing with Equity Espresso?
Is there anything you’d like to see more of or less of?
Which aspects of the newsletter do you enjoy the most?
Hit reply and say hello - or leave us feedback in the poll below:
If you enjoyed this newsletter, forward this e-mail to a friend.
If you’re that friend, subscribe here.
DISCLAIMER: Please note that the information provided in this newsletter is for educational purposes only and should not be considered financial advice. It is not intended to encourage you to buy/sell assets or make economic decisions. We strongly recommend conducting your research before making any investment.